SCHEMBL6636062

SCHEMBL6636062

CCOC(=O)Cn1c(COc2ccc(C#N)cc2)nc2cc(N)ccc21

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.52
NPC1 O15118 3/20 0.52
NLRP3 Q96P20 1/20 0.52
NPSR1 Q6W5P4 1/20 0.48
HSD17B10 Q99714 3/20 0.48
HTT P42858 2/20 0.48
PPARG P37231 1/20 0.44
CNR2 P34972 1/20 0.43
ALOX5AP P20292 4/20 0.43
MEN1 O00255 3/20 0.42
KMT2A Q03164 3/20 0.42
RAB9A P51151 2/20 0.42
KDM4E B2RXH2 3/20 0.41
RAD52 P43351 1/20 0.41
ALDH1A1 P00352 3/20 0.41
HPGD P15428 1/20 0.41
ALOX15 P16050 1/20 0.40
CACNA1B Q00975 1/20 0.40
APBA1 Q02410 1/20 0.40
CYP1A2 P05177 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6633348 0.92 PPARG (0.48) MAPTNPC1NLRP3NPSR1HSD17B10
SCHEMBL6634205 0.86 KMT2A (0.51) MAPTNPC1NLRP3NPSR1HSD17B10
SCHEMBL6639694 0.80 IRAK4 (0.45) MAPTNPC1NLRP3NPSR1PPARG
SCHEMBL6635871 0.80 BRPF1 (0.48) MAPTNPC1NLRP3NPSR1HSD17B10
SCHEMBL6636068 0.80 CNR2 (0.42) MAPTNPSR1HSD17B10HTTCNR2
SCHEMBL6635786 0.80 MAPT (0.44) MAPTNPC1NLRP3NPSR1HSD17B10
SCHEMBL6635781 0.78 MAPT (0.42) MAPTNPC1NLRP3NPSR1HSD17B10
SCHEMBL6639197 0.77 MAPT (0.42) MAPTNPC1NLRP3NPSR1HSD17B10
SCHEMBL6642117 0.76 F2 (0.47) MAPTNPC1NLRP3NPSR1HTT
SCHEMBL6635525 0.75 AR (0.48) MAPTNPSR1HSD17B10HTTALOX5AP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1100795-B1 DISUBSTITUTED BICYCLIC HETEROCYCLES HAVING, IN PARTICULAR, A THROMBIN INHIBITIVE EFFECT BOEHRINGER INGELHEIM PHARMA (DE) 2004-06-09 EP disclosed
EP-1100795-A1 DISUBSTITUTED BICYCLIC HETEROCYCLES HAVING, IN PARTICULAR, A THROMBIN INHIBITIVE EFFECT BOEHRINGER INGELHEIM ZENTRALE GMBH (DE) 2001-05-23 EP disclosed
US-6121308-A INDOLE AND BENZIMIDAZOLE ANTITHROMBOTIC COMPOUNDS, SUCH AS 1-METHYL-2-(N-(4-AMIDINOPHENYL)-AMINOMETHYL)-5-(N-(HYDROXYCARBONYLMETHYL) -QUINOLINE-8-SULPHONYLAMINO)-INDOLE BOEHRINGER INGELHEIM KG (DE) 2000-09-19 US disclosed
WO-2000008014-A1 DISUBSTITUTED BICYCLIC HETEROCYCLES HAVING, IN PARTICULAR, A THROMBIN INHIBITIVE EFFECT BOEHRINGER INGELHEIM PHARMA KG (DE) 2000-02-17 WO disclosed